Polynovo Ltd has released a press release.
US Regulatory Update
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Polynovo
- NovoSkin awarded BioInnovationSA Grant
- Feasibility Study Extended by 12 Months
- CZD: Termination of Metabolic vend-in proposal
- PolyNovo US Patent Allowed
- PolyNovo US Collaboration Update
Later from Polynovo
- Additional BARDA Option Exercised Valued at US$2.4m
- BTM use in Diabetes Islet Cell Transplantation Study
- Financial result guidance
- Full Year Statutory Accounts and Appendix 4E
- US Market Entry-PolyNovo
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo